Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2014
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140335549 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
11/06/2014US20140328948 Buffered compositions for dialysis
11/04/2014US8877214 Pharmaceutical composition for modified release
10/2014
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871436 Immunostimulatory oligonucleotides and uses thereof
10/21/2014US8865690 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
10/21/2014US8865161 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/09/2014WO2014164771A1 Bromodomain inhibitors
10/09/2014WO2014163520A1 Preparation for treating proctological, urological and gynaecological diseases
10/09/2014WO2014161919A1 Therapeutic uses of empagliflozin
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140303126 Novel quinuclidine derivatives and medicinal compositions containing the same
10/09/2014US20140303077 Albumin fusion proteins
10/08/2014EP2785349A1 Combination treatment of cancer
10/07/2014US8853193 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
10/02/2014WO2014160877A1 Prevention and treatment of kidney damage by bile acids
10/02/2014WO2014159227A1 Use of shroom3 in chronic kidney disease and chronic allograft nephropathy
10/02/2014WO2014159012A1 Azetidinyloxyphenylpyrrolidine compounds
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157437A1 Propellane derivative
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014157137A1 Oral administration preparation with masked bitterness of silodosin
10/02/2014WO2014154168A1 Bicyclic substituted pyrimidine pde-5 inhibitor prodrug
10/02/2014WO2014154026A1 PI3K AND/OR mTOR INHIBITOR PRODRUG
09/2014
09/30/2014US8846906 5HT2C receptor modulators
09/25/2014WO2014151853A1 Methods of treating bladder cancer
09/25/2014WO2014151680A1 Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies
09/25/2014WO2014150873A1 Sequestrants of advanced glycation end product (age) precursors
09/25/2014WO2014150314A1 Therapeutic uses for vegfr1 antibodies
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148489A1 Cyclic peptide
09/25/2014WO2014148455A1 Terpenoid derivative
09/25/2014WO2014148422A1 Licorice hydrolysis extraction composition
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/24/2014EP2781521A1 Novel spiroindoline compound, and medicinal agent comprising same
09/24/2014EP2781520A1 Three-ring pi3k and/or mtor inhibitor
09/24/2014EP2780371A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
09/24/2014EP2780370A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
09/24/2014EP2780369A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
09/23/2014US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/23/2014US8841254 Method for treatment of anxiety
09/23/2014CA2602968C Crystals of morphinan derivative and process for producing the same
09/23/2014CA2575341C Trpv1 agonists, formulations containing them and uses thereof
09/18/2014WO2014145813A1 Abiraterone acetate formulation
09/18/2014WO2014144623A1 Isolation of factor h from fraction i paste
09/18/2014WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor
09/18/2014WO2014142273A1 Dihydropyridazine-3,5-dione derivative
09/18/2014WO2014142219A1 Guanidinobenzoic acid ester compound
09/18/2014WO2014142127A1 Phenylxanthene derivative
09/18/2014WO2014142092A1 Novel pi polyamide
09/18/2014WO2014140695A1 Solid oral formulation of a pyrrolidine substituted flavone compound
09/18/2014WO2014140284A1 Use of linagliptin in cardio- and renoprotective antidiabetic therapy
09/18/2014WO2014139282A1 Pharmaceutical compositions for treating cancer of genital system and preparation method therefor
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140271695 Immunogenic lhrh compositions and methods relating thereto
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/17/2014EP2776393A1 Nampt inhibitors
09/17/2014EP2776130A1 A ddr1 antagonist or an inhibitor of ddr1 gene expression for use in the prevention or treatment of crescentic glomerulonephritis
09/17/2014EP2776129A1 Calcimimetics and methods for their use
09/16/2014US8835474 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
09/16/2014US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
09/16/2014US8834897 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
09/12/2014WO2014138738A1 Methods of treating acute kidney injury
09/12/2014WO2014136036A1 Nutritional and medicinal oral composition for veterinary use
09/12/2014WO2014136035A1 Nutritional and medicinal oral composition for veterinary use
09/12/2014WO2014135561A1 New dihydroquinoline-2-one derivatives as aldosterone synthase (cyp1 1 b2 or cyp1 1 b1 ) inhibitors
09/10/2014EP2774618A2 Pharmaceutical composition based on epigallocatechin gallate-containing nano-micelles and use thereof to treat atopic dermatitis, crohn's disease, adenomyosis and hyperplastic prostate disorders
09/10/2014EP2773644A1 Azetidine compounds, compositions and their use as inhibitors of soluble epoxide hydrolase
09/10/2014EP2773364A1 Stable pharmaceutical formulations of growth factor peptides
09/09/2014US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA
09/09/2014CA2614698C Use of mglur5 (esp. afq056) in gi (esp. gerd)
09/04/2014US20140249198 Melatonin and its use in preventing postoperative complications
09/04/2014US20140249185 Therapeutic Agents Useful for Treating Pain
09/04/2014US20140248700 Method of Differentiation of Morula or Inner Cell Mass Cells and Method of Making Lineage-Defective Embryonic Stem Cells
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/03/2014EP2772491A1 Crystals of androgen receptor antagonist compound
09/03/2014EP2772490A1 Aminoalkyl-substituted n-thienyl benzamide derivative
09/03/2014EP2772261A1 Orally administered adsorbent
09/03/2014EP2772252A1 Oxybutynin-containing transdermal absorption preparation
09/03/2014EP2771320A1 Cyclohexylamines
09/02/2014US8822637 Somatostatin analogues
09/02/2014US8822636 Peptides for activation and inhibition of δPKC
09/02/2014US8822480 Bicyclic heterocycle derivatives and use thereof as GPR119 modulators
09/02/2014US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
08/2014
08/28/2014WO2014107531A3 Desensitizing drug products containing lidocaine, thymol and ethanol
08/28/2014WO2013103811A3 Slit-robo signaling for diagnosis and treatment of kidney disease
08/28/2014US20140243284 Biologically active macrolides, compositions, and uses thereof
08/27/2014EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto
08/27/2014EP2768526A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
08/26/2014US8815876 Bicyclic heterocycle derivatives and methods of use thereof
08/26/2014US8815806 Yellow pea seed protein-derived peptides
08/26/2014US8815801 Controlled release composition and method of producing the same
08/21/2014WO2014126972A1 Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy
08/21/2014WO2014125291A1 Agents which induce lymphangiogenesis for use in the treatment of cystic kidney disease
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 562